Debanjan Bhowmik

Debanjan Bhowmik

Auto-generated profile, based on publicly available information

Debanjan Bhowmik

BRIC-Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, Kerala, India

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2019 in ACS Nano
Verified
Journal Article
Closed access
JHJingtian Hu
Jingtian Hu
DWDanqing Wang
Danqing Wang
DBDebanjan Bhowmik
Debanjan Bhowmik
TLTingting Liu
Tingting Liu
Shikai DengShikai Deng
Shikai Deng
TOTeri W. Odom
Teri W. Odom

1 October 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
NNNeha Nandwani
Neha Nandwani
DBDebanjan Bhowmik
Debanjan Bhowmik
CGCamille Glaser
Camille Glaser
MCMatthew Carter Childers
Matthew Carter Childers
RGRama Reddy Goluguri
Rama Reddy Goluguri
KRKathleen M. Ruppel
Kathleen M. Ruppel
At the molecular level, clinical hypercontractility associated with many hypertrophic cardiomyopathy (HCM)-causing mutations in β-cardiac myosin appears to be driven by their disruptive effect on the energy-conserving, folded-back ‘OFF’-state of myosin, which results in increased number of heads free to interact with actin and produce force. While many characterized mutations likely act by directly perturbing intramolecular interfaces stabilizing the OFF-state, others may function allosterically by altering conformational states of the myosin motor. We investigate two such allosteric HCM mutations, Y115H (Transducer) and E497D (Relay helix), which do not directly contact OFF-state interfaces. Biochemical analyses and high-resolution crystallography reveal that both mutations increase active myosin head availability likely by destabilizing the pre-powerstroke conformation required for OFF-state formation. We propose that destabilization of the folded-back state of myosin, either directly or allosterically, represents a common molecular mechanism underlying hypercontractility in HCM across a broader spectrum of pathogenic mutations than previously recognized.

3 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
NNNeha Nandwani
Neha Nandwani
DBDebanjan Bhowmik
Debanjan Bhowmik
MCMatthew Carter Childers
Matthew Carter Childers
RGRama Reddy Goluguri
Rama Reddy Goluguri
ADAminah Dawood
Aminah Dawood
KRKathleen M. Ruppel
Kathleen M. Ruppel
At the molecular level, clinical hypercontractility associated with many hypertrophic cardiomyopathy (HCM)-causing mutations in β-cardiac myosin appears to be driven by their disruptive effect on the energy-conserving, folded-back, super relaxed (SRX) ‘OFF’-state of myosin. A pathological increase in force production results from release of heads from this ‘OFF’-state, which results in an increase in the number of heads free to interact with actin and produce force. Pathogenic mutations in myosin can conceivably disrupt the ‘OFF’-state by (1) directly affecting the intramolecular interfaces stabilizing the folded-back state, or (2) allosterically destabilizing the folded-back state via disruption of diverse conformational states of the myosin motor along its chemomechanical cycle. However, very little is understood about the mutations that fall in the latter group. Here, using recombinant human β-cardiac myosin, we analysed the biomechanical properties of two such HCM-causing mutations, Y115H (in the transducer) and E497D (in the relay helix), neither of which falls in the regions that interact to stabilize myosin’s folded-back state. We find these mutations have diverse effects on the contractility parameters of myosin, yet the primary hypercontractile change in both cases is the destabilization of the ‘OFF’-state of myosin and increased availability of active myosin heads for actin-binding. Experimental data and molecular dynamics simulations indicate that these mutations likely destabilize the pre-powerstroke state of myosin, the conformation the motor adopts in the inactive folded-back state. We propose that destabilization of the folded-back state of myosin, directly and/or allosterically, is the molecular basis of hypercontractility in HCM in a far greater number of pathogenic mutations than currently thought.

19 February 2025 in Biosensors and Bioelectronics
Verified
Journal Article
Open access
ABArianna Bonizzi
Arianna Bonizzi
LSLorena Signati
Lorena Signati
MGMaria Grimaldi
Maria Grimaldi
MTMarta Truffi
Marta Truffi
FPFrancesca Piccotti
Francesca Piccotti
Carlo Francesco MorassoCarlo Francesco Morasso
Carlo Francesco Morasso
Extracellular vesicles (EVs) are a subgroup of the circulating particles, released by cells in both normal and diseased states, carrying active biomolecules. They have gained significant attention as potential cancer biomarkers, particularly in breast cancer (BC). Previous research showed variations in EVs content and quantity between BC patients and healthy controls (HC). However, studying the biochemical profile of EVs remains challenging due to their low abundance and complex composition. Additionally, EVs may interact with other plasma components, like lipoproteins (LPs), forming a so called "biomolecular corona" that further complicates their analysis. Here, Raman spectroscopy (RS) is proposed as a fast tool to obtain the biochemical profile of circulating EVs in the context of BC. RS was employed to differentiate various extracellular particles (EPs) in blood, including LPs and EVs. The study also evaluated RS's capability to quantify major classes of biomolecules and compared these results with those obtained by traditional biochemical assays. Finally, compositional differences in large EVs (lEVs) and small EVs (sEVs) were assessed between HC and BC patients. RS revealed the existence of distinct biochemical signatures associated with BC, highlighting increased levels of nucleic acids and lipids in the BC group.

9 January 2026 in Nanoscale
Verified
Journal Article
Closed access
PDF file
AAAbhirami Ajith
Abhirami Ajith
STSudhanshu Mani Tripathi
Sudhanshu Mani Tripathi
PJPoornendhu Jayasree
Poornendhu Jayasree
HSHarikrishnan K. Surendran
Harikrishnan K. Surendran
MCMekhla Chowdhury
Mekhla Chowdhury
DBDebanjan Bhowmik
Debanjan Bhowmik
Lipid-coated AgNPs capture lipophilic Aβ oligomers, which are selectively detected by Rose Bengal-functionalized AgNPs through SERS originating from AgNP-proximity-induced plasmonic hot spots.

10 June 2025 in Langmuir
Verified
Journal Article
Closed access
IMIrfan Shafi Malik
Irfan Shafi Malik
NNNithya K. Nair
Nithya K. Nair
ABAthira B
Athira B
SMShambhavi Mishra
Shambhavi Mishra
SUShreya Unnithan
Shreya Unnithan
DBDebanjan Bhowmik
Debanjan Bhowmik